Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) dropped 9.8% during trading on Friday . The stock traded as low as $0.16 and last traded at $0.16. Approximately 1,500 shares were traded during trading, a decline of 80% from the average daily volume of 7,517 shares. The stock had previously closed at $0.17.
Ascletis Pharma Trading Down 9.8 %
The company’s 50-day moving average is $0.16 and its 200 day moving average is $0.17.
About Ascletis Pharma
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
Featured Articles
- Five stocks we like better than Ascletis Pharma
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Best Aerospace Stocks Investing
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What is a Low P/E Ratio and What Does it Tell Investors?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
